Aura Biosciences Inc
NASDAQ:AURA
Income Statement
Earnings Waterfall
Aura Biosciences Inc
Income Statement
Aura Biosciences Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(35)
|
(33)
|
(47)
|
(54)
|
(60)
|
(67)
|
(73)
|
(78)
|
(85)
|
(88)
|
(90)
|
(93)
|
(96)
|
(103)
|
(109)
|
(113)
|
|
| Selling, General & Administrative |
(10)
|
(11)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(20)
|
(20)
|
(20)
|
(21)
|
(22)
|
(23)
|
(23)
|
(23)
|
(23)
|
|
| Research & Development |
(25)
|
(23)
|
(32)
|
(37)
|
(42)
|
(48)
|
(54)
|
(58)
|
(65)
|
(68)
|
(70)
|
(71)
|
(73)
|
(80)
|
(86)
|
(91)
|
|
| Operating Income |
(35)
N/A
|
(33)
+5%
|
(47)
-41%
|
(54)
-15%
|
(60)
-11%
|
(67)
-11%
|
(73)
-10%
|
(78)
-6%
|
(85)
-9%
|
(88)
-3%
|
(90)
-3%
|
(93)
-3%
|
(96)
-3%
|
(103)
-7%
|
(109)
-6%
|
(113)
-4%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
1
|
2
|
4
|
6
|
7
|
9
|
9
|
10
|
10
|
9
|
8
|
8
|
7
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(35)
N/A
|
(33)
+6%
|
(47)
-40%
|
(54)
-15%
|
(59)
-9%
|
(63)
-8%
|
(68)
-8%
|
(71)
-4%
|
(76)
-8%
|
(78)
-3%
|
(81)
-3%
|
(83)
-3%
|
(87)
-5%
|
(95)
-9%
|
(101)
-7%
|
(106)
-5%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(35)
|
(33)
|
(47)
|
(54)
|
(59)
|
(63)
|
(68)
|
(71)
|
(76)
|
(79)
|
(81)
|
(83)
|
(87)
|
(95)
|
(101)
|
(106)
|
|
| Net Income (Common) |
(46)
N/A
|
(38)
+17%
|
(52)
-35%
|
(55)
-7%
|
(59)
-7%
|
(63)
-8%
|
(68)
-8%
|
(71)
-4%
|
(76)
-8%
|
(79)
-3%
|
(81)
-3%
|
(83)
-3%
|
(87)
-4%
|
(95)
-9%
|
(101)
-7%
|
(106)
-5%
|
|
| EPS (Diluted) |
-1.58
N/A
|
-1.31
+17%
|
-1.77
-35%
|
-1.88
-6%
|
-1.96
-4%
|
-1.67
+15%
|
-1.8
-8%
|
-1.85
-3%
|
-1.93
-4%
|
-1.59
+18%
|
-1.62
-2%
|
-1.67
-3%
|
-1.75
-5%
|
-1.9
-9%
|
-1.74
+8%
|
-1.61
+7%
|
|